Which progesterone assay should be ordered for clinical decision‑making: free progesterone, total progesterone measured by liquid chromatography‑tandem mass spectrometry (LC‑MS/MS), or a standard immunoassay?

Order Total Progesterone by LC-MS/MS for Clinical Decision-Making

For clinical progesterone measurement, order total serum progesterone measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS), not free progesterone or standard immunoassays. LC-MS/MS provides superior accuracy and specificity compared to immunoassays, particularly at lower concentrations where clinical decisions are often made 1, 2.

Why LC-MS/MS is the Preferred Method

Superior Accuracy at All Concentration Ranges

Standard immunoassays consistently overestimate progesterone levels, especially at low concentrations (below 5 nmol/L or approximately 1.6 ng/mL), with increasingly high variability and deviation 3. This is clinically problematic because:

• Immunoassays show significant calibration biases and sample-specific deviations when compared to LC-MS/MS reference methods 1
• Direct progesterone immunoassays are "too inaccurate to be used quantitatively" at low measurements 3
• Mean progesterone levels differ substantially across different immunoassay analyzers, even when measuring the same samples 4

Specificity and Lack of Cross-Reactivity

LC-MS/MS combines chromatographic separation with mass/charge ratio detection, making it far more specific than immunoassays 5. Immunoassays suffer from:

• Cross-reactivity with other steroid metabolites
• Matrix effects that vary between samples
• Inability to distinguish progesterone from structurally similar compounds

Recent validation studies demonstrate that LC-MS/MS methods achieve:

• Excellent linearity (R² > 0.992)
• High sensitivity (LOD: 0.05-0.5 ng/mL)
• Superior precision and accuracy (%CV < 15%, recovery: 91.8-110.7%) 6

Clinical Contexts Where This Matters Most

In Vitro Fertilization (IVF) Monitoring

The detection of premature luteinization during IVF hyperstimulation requires accurate measurement of small increases in late follicular phase progesterone. Immunoassays are unreliable for this purpose because they consistently overestimate low progesterone concentrations, potentially leading to incorrect clinical decisions about cycle cancellation or timing of embryo transfer 3, 4.

Ovulation Confirmation and Luteal Phase Assessment

When confirming ovulation or assessing luteal phase adequacy, the difference between 2 ng/mL and 5 ng/mL can change clinical management. Immunoassays show inter-assay coefficients of variation often exceeding 10% at these critical thresholds 4.

Early Pregnancy Monitoring

For predicting early pregnancy viability or ectopic pregnancy, precise progesterone measurement is essential. The "quite large bias among participating laboratories" using immunoassays means that reference ranges and cutoff values are not transferable between methods 7.

What About Free Progesterone?

Do not order free progesterone. The evidence base for clinical decision-making uses total progesterone measurements. Free progesterone assays:

• Lack standardization and validation for clinical use
• Have no established reference ranges
• Are not supported by clinical outcome studies
• Add unnecessary complexity without proven benefit

Practical Implementation

If LC-MS/MS is Available

Order: "Serum progesterone by LC-MS/MS"

• Provides measurement range of 0.04-72.5 ng/mL (0.127-231 nmol/L) 2
• Expanded measurement uncertainty ≤3.7% 2
• Results are traceable to international reference standards

If LC-MS/MS is Not Available

If your laboratory only offers immunoassays:

1. Understand the specific analyzer and method your laboratory uses
2. Interpret results cautiously, especially values <5 nmol/L (1.6 ng/mL)
3. Use laboratory-specific reference ranges rather than published cutoffs from other institutions 4
4. Consider sending samples to a reference laboratory with LC-MS/MS capability for critical clinical decisions (IVF monitoring, equivocal early pregnancy cases)

Common Pitfalls to Avoid

• Do not assume immunoassay results are interchangeable between different platforms or laboratories—they can vary by up to 47% 5
• Do not use published progesterone thresholds from studies that used different assay methods than your laboratory
• Do not rely on low progesterone values from immunoassays (<5 nmol/L) for definitive clinical decisions without confirmatory LC-MS/MS testing 3
• Do not order "free progesterone"—this is not the standard of care and lacks clinical validation

The Bottom Line

LC-MS/MS is the reference standard for progesterone measurement and should be used whenever available, particularly for low-concentration measurements where immunoassays are demonstrably inaccurate 1, 2. The improved accuracy directly impacts clinical decision-making in fertility treatment, early pregnancy assessment, and ovulation monitoring—contexts where small differences in progesterone levels change management and affect patient outcomes.